These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 6716959

  • 21. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G, Presser HJ, Urbahn H.
    Z Gesamte Inn Med; 1989 Apr 15; 44(8):235-40. PubMed ID: 2662657
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS.
    J Cardiothorac Vasc Anesth; 2008 Feb 15; 22(1):47-52. PubMed ID: 18249330
    [Abstract] [Full Text] [Related]

  • 26. Chemorheological studies of the effect of heparin on the course of coagulation.
    Overholser KA, Baysinger CB, Harris TR, Deveau T.
    Thromb Haemost; 1976 Apr 30; 35(2):447-59. PubMed ID: 989642
    [Abstract] [Full Text] [Related]

  • 27. Individual responses to heparinization for extracorporeal circulation.
    Friesen RH, Clement AJ.
    J Thorac Cardiovasc Surg; 1976 Dec 30; 72(6):875-9. PubMed ID: 994537
    [Abstract] [Full Text] [Related]

  • 28. [Heparin management by activated coagulation time during cardiopulmonary bypass].
    Shikano K, Shinpo H, Nasu M, Morimoto T, Suzuki T, Yada I, Kusagawa M.
    Kyobu Geka; 1981 Dec 30; 34(12):934-7. PubMed ID: 7349352
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald DJ, Patel A, Body SC, Garvin S.
    Perfusion; 2009 Mar 30; 24(2):93-6. PubMed ID: 19654150
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [The "activated coagulation time (ACT)": two simple screening methods for evaluating coagulation disorders in dogs].
    Glaus T, Hudak-Glaus D, Hoeptner C, Arnold P, Lutz H.
    Schweiz Arch Tierheilkd; 1996 Mar 30; 138(11):532-6. PubMed ID: 9026910
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Modification of the global coagulation tests for the dog. Significance for the monitoring of heparin therapy].
    Mischke R, Nolte I.
    Tierarztl Prax; 1991 Oct 30; 19(5):561-6. PubMed ID: 1759273
    [Abstract] [Full Text] [Related]

  • 40. Heparin-lock maintenance with ten units of sodium heparin in one milliliter of normal saline solution.
    Hanson RL, Grant AM, Majors KR.
    Surg Gynecol Obstet; 1976 Mar 30; 142(3):373-6. PubMed ID: 1251318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.